Keyphrases
Ceramide
98%
Coronary Artery Disease
54%
Atherosclerotic Plaque
45%
Vascular Studies
40%
Tampere
40%
Phosphatidylcholine
36%
Cardiovascular Mortality
34%
Event Risk
28%
Coronary Events
28%
Risk Test
27%
Plasma Ceramides
24%
Cardiovascular Disease
22%
Risk Score
21%
Young Finns Study
20%
All-cause Mortality
19%
Hazard Ratio
18%
Cardiovascular Risk
18%
Genome-wide Association Study
18%
Overall Mortality
17%
High Risk
17%
Low-density Lipoprotein Cholesterol (LDL-C)
17%
Peripheral Arterial Disease
17%
LDL Cholesterol
16%
Cardiovascular Risk Prediction
16%
Acute Coronary Syndrome
16%
Furin
16%
Low-density Array
16%
Serum Levels
14%
Lipidome
14%
Trimethylamine N-oxide
14%
Comorbidity
14%
Aorta
13%
Genome-wide Expression
13%
Plaque
13%
Sphingolipids
12%
Lipids
12%
Confidence Interval
12%
Proprotein Convertase Subtilisin/kexin
12%
Secondary Prevention
11%
BeadChip
11%
Illumina
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Carotid Intima-media Thickness (cIMT)
11%
Non-diabetic
11%
Risk Factors
11%
Quantitative PCR
11%
Risk Prediction
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
10%
Genotype
10%
Atherosclerotic Cardiovascular Disease (ASCVD)
10%
Biochemistry, Genetics and Molecular Biology
Ceramide
100%
Blood Plasma
39%
Lecithin
36%
Lipid
32%
Cardiovascular Mortality
23%
Phospholipid
18%
All Cause Mortality
18%
Blood Level
17%
Trimethylamine N-Oxide
16%
Genome-Wide Association Study
16%
Metabolite
16%
Lipoprotein
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Liquid Chromatography-Mass Spectrometry
11%
Sphingolipid
11%
Metabolic Pathway
11%
Triglyceride
10%
Blood Lipids
10%
Statin
10%
TaqMan
10%
Single-Nucleotide Polymorphism
9%
Lipidome
9%
Enzyme
9%
Macrophage
9%
Arginase
9%
Genomics
9%
Gene Expression
9%
Serum Lipids
9%
Genotyping
9%
Glucose Metabolism
9%
Insulin Resistance
9%
Comorbidity
9%
Upregulation
8%
Allele
8%
Proprotein Convertase
8%
Subtilisin
8%
Kexin
8%
Microarrays
8%
Lipidomics
8%
Genetic Architecture
8%
Leukocyte
8%
Locus Control Region
8%
MicroRNA
8%
Lipoprotein Metabolism
8%
Upstream Stimulatory Factor 1
8%
Tumor Necrosis Factor Alpha
8%
Tumor Necrosis Factor
8%
Gene Set Enrichment Analysis
8%
Intraocular Pressure
8%
Blood Pressure
8%
Medicine and Dentistry
Ceramide
70%
Atherosclerosis
37%
Ischemic Heart Disease
32%
Cardiovascular Disease
28%
Cardiovascular System
23%
Coronary Artery Disease
19%
Egg Lecithin
19%
Disease
18%
Low Density Lipoprotein Cholesterol
16%
Biological Marker
16%
Hazard Ratio
15%
Cardiovascular Risk
13%
Risk Stratification
13%
Maturity Onset Diabetes of the Young
12%
Secondary Prevention
11%
Macrophage
11%
Upregulation
11%
Apoplexy
10%
Artery
10%
Cardiovascular Mortality
10%
Shared Decision Making
10%
Middle Age
9%
All Cause Mortality
9%
Triacylglycerol
9%
Phospholipid
9%
Thrombosis
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Comorbidity
9%
Receptor
8%
Liquid Chromatography-Mass Spectrometry
8%
Cytokine
8%
Trimethylamine
8%
Arginase
8%
Tumor Necrosis Factor Antibody
8%
Lipidomics
8%
Coronary Risk
8%
Tumor Necrosis Factor
8%
Carotid Endarterectomy
8%
First Trimester Pregnancy
8%
microRNA
8%
microRNA 146a
8%
microRNA 34a
8%
microRNA 210
8%
Netrin 1
8%
Arteriosclerosis Obliterans
8%
Diabetes
8%
Cardiometabolic Risk
8%
Endothelial Dysfunction
8%
Rheumatoid Arthritis
8%
Inflammatory Arthritis
8%
